Identification of the human 26-kD protein, interferon beta 2 (IFN-beta 2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor
about
Induction of neuronal differentiation in PC12 cells by B-cell stimulatory factor 2/interleukin 6A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP familyInterferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cellsFunctional murine interleukin 6 receptor with the intracisternal A particle gene product at its cytoplasmic domain. Its possible role in plasmacytomagenesisRevisiting the 1986 molecular cloning of interleukin 6Ozone effects on airway responsiveness, lung injury, and inflammation. Comparative rat strain and in vivo/in vitro investigationsInvolvement of a NF-kappa B-like transcription factor in the activation of the interleukin-6 gene by inflammatory lymphokinesThe second century of the antibody. Molecular perspectives in regulation, pathophysiology, and therapeutic applications.Multiple biological activities are expressed by a mouse interleukin 6 cDNA clone isolated from bone marrow stromal cells.Growth inhibition of human breast carcinoma and leukemia/lymphoma cell lines by recombinant interferon-beta 2Interleukin 2-dependent and interleukin 2-independent pathways of regulation of thymocyte function by interleukin 6.High-level expression of a bioengineered, cysteine-free hepatocyte-stimulating factor (interleukin 6)-like protein.Cytotoxic activity of an interleukin 6-Pseudomonas exotoxin fusion protein on human myeloma cellsInterleukin-6 functions as an intracellular growth factor in hairy cell leukemia in vitro.Circulating cytokines as mediators of fever.Pathophysiology of cancer cachexia.Interleukin-6 antisense oligonucleotides inhibit the growth of human myeloma cell lines.Human appendix B cells naturally express receptors for and respond to interleukin 6 with selective IgA1 and IgA2 synthesisInterleukin 1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitisExpression of ras oncogenes in cultured human cells alters the transcriptional and posttranscriptional regulation of cytokine genes.Human interleukin 6 is a direct promoter of maturation of megakaryocytes in vitro.B-cell-stimulatory factor 2 (beta 2 interferon) functions as a second signal for interleukin 2 production by mature murine T cellsInterrelations between interleukin-6, interleukin-1 beta, plasma C-reactive protein values, and in vitro C-reactive protein generation in patients with inflammatory bowel disease.Peripheral blood monocyte cytokine production and acute phase response in inflammatory bowel disease.Interleukin 6 gene expression in normal and neoplastic B cells.Loci associated with N-glycosylation of human immunoglobulin G show pleiotropy with autoimmune diseases and haematological cancers.Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasiasSOCS-3 negatively regulates innate and adaptive immune mechanisms in acute IL-1-dependent inflammatory arthritis.T cells induce terminal differentiation of transformed B cells to mature plasma cell tumors.The paradigm of IL-6: from basic science to medicineInterleukin 6 in autoimmune and inflammatory diseases: a personal memoirKi-1 positive large cell anaplastic lymphoma: multiple bone lytic lesions and interleukin-6.Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression.Solitary plasmacytoma in the setting of Langerhans cell histiocytosis.Regulatory effects of interleukin-6 in immunoglobulin G immune-complex-induced lung injury.Effectiveness of workplace rehabilitation interventions in the treatment of work-related upper extremity disorders: a systematic review.The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia.Associations of Circulating Soluble Tumor Necrosis Factor-α Receptors 1 and 2 with Interleukin-6 Levels in an Aging Cohort of Injection Drug Users with or at High Risk for HIV InfectionExpression of an exogenous interleukin 6 gene in human Epstein Barr virus B cells confers growth advantage and in vivo tumorigenicityInterleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and post-transcriptional mechanisms.
P2860
Q24297617-955F06C3-EA3F-4696-9C8E-B1683AFED992Q24310416-1AF4AFB7-EDA3-4D75-BA4E-32D458C3257FQ24322083-0E749707-58CE-4151-BDDF-81649B9C6C75Q24682989-E3A864E6-8DF8-4A02-93AF-C104A0E55821Q26998608-5D33DC29-C9D9-472F-9345-11279F43BA7DQ28376478-09F3303B-E7F7-4242-B953-06296EA8BE9FQ28646316-C336081C-1FC3-4854-B92B-99B314F84C63Q33581541-3132EA93-BD88-4E40-A1BA-72881E1B9A20Q33650453-C835BD2C-AB4D-4811-80FB-4782F2261090Q33661906-BE249BD4-57BB-472B-808F-4C00D323EA9EQ33671836-F413778E-7E49-461B-BDFF-5B4D09B3527DQ33684419-696A8D80-F8EA-4464-BF02-2CEC9BD8FB1CQ33688127-0AD115B3-B9B0-4B26-8744-2ED9D80C3BF4Q33907983-C304ACF5-5DAB-4759-922D-DFC7C40770F0Q34102600-3D77E31D-A45F-4FC1-9BC1-ECCE90B120CEQ34139514-DA0F121D-E5A2-4B98-8739-281F578113DAQ34194873-765FD592-596E-4F87-AD0D-7E7A5A9115DFQ34225676-7F2DD733-3822-46E6-996E-AB1C584DFB9DQ34260899-08F478AE-78D8-4C3B-AD2A-DFFF09A9292AQ34261945-E77987EA-397B-46DC-B543-17F996BE2EB6Q34294815-2E9F5A89-97E2-433C-8FE3-FD37D2FC7B1CQ34359809-EEFBA78E-8C1D-4E77-BA45-6796103889E9Q34378438-662C69DB-F18D-4880-9CA8-D220724AAB2CQ34395428-708B2E61-9700-4DD3-9602-91E1A9B566D1Q34572044-B0912891-CD89-468E-AE78-821B7D07DDA6Q34574913-011091C1-9070-4937-A25B-0F03168C7913Q34581815-BFD95649-E0F4-4376-84E2-54A4FB1D2F7BQ34619592-7D6B0783-498E-4218-A622-49143E70EE43Q34712334-9ECFE8E2-D2C0-48B7-A2E6-9D8C7927C937Q34731226-7A2274F9-CAC4-47CC-ABD0-95A211789F48Q34734696-03E6666B-575E-4E71-BA89-69A0299CC6A7Q35238472-9CFF1EFB-97D9-494B-BC45-68B83C785B9AQ35478848-2905FA47-3944-40BA-936D-EA30FA17FDD0Q35670989-58E06072-B894-4B79-B855-3EBC41E19DBBQ35763648-FD139AC4-040C-4797-9147-92B020819671Q35783336-16A1EAF3-29DD-481E-9F68-A934E297D68BQ35871035-181D9550-70D4-4739-95ED-AACED2CC9AE9Q36330047-871D6003-00F8-47A2-8AEE-CF21762C269DQ36351981-8B44C6BA-DE22-4E38-8896-F0540D181362Q36352092-585E95CF-5722-48E6-B781-2B4C1F80CA2D
P2860
Identification of the human 26-kD protein, interferon beta 2 (IFN-beta 2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
1987年學術文章
@zh
1987年學術文章
@zh-hant
name
Identification of the human 26 ...... in 1 and tumor necrosis factor
@ast
Identification of the human 26 ...... in 1 and tumor necrosis factor
@en
type
label
Identification of the human 26 ...... in 1 and tumor necrosis factor
@ast
Identification of the human 26 ...... in 1 and tumor necrosis factor
@en
prefLabel
Identification of the human 26 ...... in 1 and tumor necrosis factor
@ast
Identification of the human 26 ...... in 1 and tumor necrosis factor
@en
P2093
P2860
P356
P1476
Identification of the human 26 ...... in 1 and tumor necrosis factor
@en
P2093
Opdenakker G
Simpson RJ
Van Damme J
Van Snick J
P2860
P304
P356
10.1084/JEM.165.3.914
P407
P577
1987-03-01T00:00:00Z